Shares of other companies:
April 18, 2024 EU Moves Toward Single Capital Market Union
April 17, 2024 Bitcoin Halving 2024: Market Impact Predictions
April 14, 2024 Markets Rattle: Iran-Israel Conflict and Economic Data Ahead
April 12, 2024 Banks Brace for Earnings Amid Rate Cut Speculations
Apple’s Technical Climb To $240 By Year-End
April 15, 2024
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading
Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
AEZS Stock News and Mentions of Aeterna Zentaris Inc. Stocktwits
Updated: April 19, 2024 (06:48)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Aeterna Zentaris Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Aeterna Zentaris Inc. (AEZS).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Aeterna Zentaris stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Aeterna Zentaris Inc. (AEZS)
April 14, 2024 (06:18) / "Stocknews.com" (by Defense World Staff)
StockNews.com Begins Coverage on Aeterna Zentaris ( NASDAQ:AEZS )
Research analysts at StockNews.com began coverage on shares of Aeterna Zentaris ( NASDAQ:AEZS - Get Free Report ) ( TSE:AEZ ) in a research report issued to clients and investors on Sunday. The firm set a "sell" rating on the biopharmaceutical company's stock.
In Article Trend: Somewhat-Bullish
April 6, 2024 (06:22) / "Stocknews.com" (by Defense World Staff)
Aeterna Zentaris ( NASDAQ:AEZS ) Receives New Coverage from Analysts at StockNews.com
StockNews.com started coverage on shares of Aeterna Zentaris ( NASDAQ:AEZS - Get Free Report ) ( TSE:AEZ ) in a research report issued on Saturday. The brokerage set a "sell" rating on the biopharmaceutical company's stock. Shares of AEZS opened at $2.02 on Friday.
In Article Trend: Somewhat-Bullish
March 29, 2024 (06:46) / "Stocknews.com" (by Defense World Staff)
Aeterna Zentaris ( NASDAQ:AEZS ) Coverage Initiated at StockNews.com
StockNews.com began coverage on shares of Aeterna Zentaris ( NASDAQ:AEZS - Get Free Report ) ( TSE:AEZ ) in a research note issued on Friday. The firm set a "sell" rating on the biopharmaceutical company's stock. Shares of NASDAQ:AEZS opened at $2.19 on Friday.
In Article Trend: Somewhat-Bullish
March 28, 2024 (11:55) / "GlobeNewswire" (by Aeterna Zentaris Inc)
Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris
TORONTO and EDMONTON, March 28, 2024 ( GLOBE NEWSWIRE ) -- Aeterna Zentaris Inc. ( NASDAQ: AEZS ) ( TSX: AEZS ) ( "Aeterna" ) and Ceapro Inc. ( TSX-V: CZO. OTCQX: CRPOF ) ( "Ceapro" ) are pleased to announce that the Court of King's Bench of Alberta has issued a final order approving the ...
In Article Trend: Somewhat-Bullish
March 28, 2024 (11:55) / "GlobeNewswire" (by Ceapro Inc.)
Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris
TORONTO and EDMONTON, Alberta, March 28, 2024 ( GLOBE NEWSWIRE ) -- Aeterna Zentaris Inc. ( NASDAQ: AEZS ) ( TSX: AEZS ) ( "Aeterna" ) and Ceapro Inc. ( TSX-V: CZO. OTCQX: CRPOF ) ( "Ceapro" ) are pleased to announce that the Court of King's Bench of Alberta has issued a final order approving the ...
In Article Trend: Somewhat-Bullish
March 28, 2024 (11:55) / "Benzinga" (by Globe Newswire)
Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris - AEterna Zentaris ( NASDAQ:AEZS ) , Ceapro ( OTC:CRPOF )
TORONTO and EDMONTON, Alberta, March 28, 2024 ( GLOBE NEWSWIRE ) -- Aeterna Zentaris Inc. AEZS AEZS ( "Aeterna" ) and Ceapro Inc.
In Article Trend: Somewhat-Bullish
March 27, 2024 (13:25) / "Zacks Commentary" (by Zacks Equity Research)
Aeterna Zentaris ( AEZS ) Reports Q4 Loss, Tops Revenue Estimates
AEterna Zentaris (AEZS) delivered earnings and revenue surprises of -19.59% and 2,925%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
In Article Trend: Neutral
March 27, 2024 (12:05) / "GlobeNewswire" (by Aeterna Zentaris Inc)
Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
- Company confirms successful completion of enrollment in the pivotal DETECT Phase 3 trial ...
In Article Trend: Somewhat-Bullish
March 21, 2024 (06:14) / "Stocknews.com" (by Defense World Staff)
StockNews.com Initiates Coverage on Aeterna Zentaris ( NASDAQ:AEZS )
Equities research analysts at StockNews.com initiated coverage on shares of Aeterna Zentaris ( NASDAQ:AEZS - Get Free Report ) ( TSE:AEZ ) in a research report issued on Thursday. The brokerage set a "sell" rating on the biopharmaceutical company's stock. Shares of AEZS stock opened at $2.07 ...
In Article Trend: Somewhat-Bullish
March 13, 2024 (06:20) / "Stocknews.com" (by ABMN Staff)
StockNews.com Begins Coverage on Aeterna Zentaris ( NASDAQ:AEZS )
StockNews.com Begins Coverage on ...
In Article Trend: Somewhat-Bullish
March 13, 2024 (06:20) / "Stocknews.com" (by Defense World Staff)
StockNews.com Begins Coverage on Aeterna Zentaris ( NASDAQ:AEZS )
Analysts at StockNews.com assumed coverage on shares of Aeterna Zentaris ( NASDAQ:AEZS - Get Free Report ) ( TSE:AEZ ) in a research report issued to clients and investors on Wednesday. The firm set a "sell" rating on the biopharmaceutical company's stock. Aeterna Zentaris stock opened at ...
In Article Trend: Somewhat-Bullish
March 12, 2024 (18:10) / "GlobeNewswire" (by Aeterna Zentaris Inc)
Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
TORONTO and EDMONTON, March 12, 2024 ( GLOBE NEWSWIRE ) -- Aeterna Zentaris Inc. ( NASDAQ: AEZS ) ( TSX: AEZS ) ( "Aeterna" ) and Ceapro Inc. ( TSX-V: CZO. OTCQX: CRPOF ) ( "Ceapro" ) are pleased to announce that securityholders of both biopharmaceutical development companies approved the ...
In Article Trend: Somewhat-Bullish
March 12, 2024 (18:10) / "GlobeNewswire" (by Ceapro Inc.)
Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
TORONTO and EDMONTON, Alberta, March 12, 2024 ( GLOBE NEWSWIRE ) -- Aeterna Zentaris Inc. ( NASDAQ: AEZS ) ( TSX: AEZS ) ( "Aeterna" ) and Ceapro Inc. ( TSX-V: CZO. OTCQX: CRPOF ) ( "Ceapro" ) are pleased to announce that securityholders of both biopharmaceutical development companies approved ...
In Article Trend: Somewhat-Bullish
March 5, 2024 (07:48) / "Stocknews.com" (by Defense World Staff)
Aeterna Zentaris ( NASDAQ:AEZS ) Earns Sell Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Aeterna Zentaris ( NASDAQ:AEZS - Get Free Report ) ( TSE:AEZ ) in a research note issued on Tuesday. The brokerage set a "sell" rating on the biopharmaceutical company's stock.
In Article Trend: Somewhat-Bullish
February 27, 2024 (12:25) / "Benzinga" (by Globe Newswire)
Global Cancer Cachexia Market Size is Estimated to Reach USD 4.74 billion by 2031, Growing at a CAGR of 4.7%: Straits Research - Pfizer ( NYSE:PFE )
New York, United States, Feb. 27, 2024 ( GLOBE NEWSWIRE ) -- Increasing Prevalence of Cancer Cachexia to Drive the Global Cancer Cachexia Market According to the International Agency for Research on Cancer-Globocan 2020 report, there will be 19,292,789 new cancer cases and 9,958,133 ...
In Article Trend: Neutral
February 26, 2024 (12:30) / "GlobeNewswire" (by Ceapro Inc.)
Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company
TORONTO and EDMONTON, Alberta, Feb. 26, 2024 ( GLOBE NEWSWIRE ) -- Aeterna Zentaris Inc. ( NASDAQ: AEZS ) ( TSX: AEZS ) ( "Aeterna Zentaris" ) and Ceapro Inc. ( TSXV: CZO ) ( OTCQX: CRPOF ) ( "Ceapro" ) , two innovative biopharmaceutical development companies, are pleased to announce today that ...
In Article Trend: Somewhat-Bullish
February 26, 2024 (12:30) / "GlobeNewswire" (by Aeterna Zentaris Inc)
Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company
TORONTO and EDMONTON, Feb. 26, 2024 ( GLOBE NEWSWIRE ) -- Aeterna Zentaris Inc. ( NASDAQ: AEZS ) ( TSX: AEZS ) ( "Aeterna Zentaris" ) and Ceapro Inc. ( TSXV: CZO ) ( OTCQX: CRPOF ) ( "Ceapro" ) , two innovative biopharmaceutical development companies, are pleased to announce today that leading ...
In Article Trend: Somewhat-Bullish
February 26, 2024 (07:50) / "Stocknews.com" (by Defense World Staff)
Aeterna Zentaris ( NASDAQ:AEZS ) Research Coverage Started at StockNews.com
Equities researchers at StockNews.com assumed coverage on shares of Aeterna Zentaris ( NASDAQ:AEZS - Get Free Report ) ( TSE:AEZ ) in a research report issued to clients and investors on Monday. The firm set a "sell" rating on the biopharmaceutical company's stock.
In Article Trend: Somewhat-Bullish
February 26, 2024 (07:20) / "Stocknews.com" (by ABMN Staff)
Aeterna Zentaris ( NASDAQ:AEZS ) Receives New Coverage from Analysts at StockNews.com
Aeterna Zentaris ( NASDAQ:AEZS ) Receives New Coverage from Analysts at ...
In Article Trend: Somewhat-Bullish
February 23, 2024 (14:00) / "GlobeNewswire" (by Ceapro Inc.)
Ceapro Provides Business Update on Progress of Ongoing Development Programs, Technology and Cosmeceutical Base Business
EDMONTON, Alberta, Feb. 23, 2024 ( GLOBE NEWSWIRE ) -- Ceapro Inc. ( TSX-V: CZO. OTCQX: CRPOF ) ( "Ceapro" or the "Company" ) , today provided an update on its progress across its current business.
In Article Trend: Somewhat-Bullish
Related stocks from Healthcare sector
This website uses cookies to ensure you get the best experience on our website